UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

Journal of clinical oncology, 2010-03, Vol.28 (7), p.1145-1153

2010

Volltextzugriff (PDF)

X chromosomal abnormalities in basal-like human breast cancer

Cancer cell, 2006-02, Vol.9 (2), p.121-132

2006

Volltextzugriff (PDF)

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups

JAMA : the journal of the American Medical Association, 2007-12, Vol.298 (24), p.2869

2007

Volltextzugriff (PDF)

A recurrent mutation in PALB2 in Finnish cancer families

Nature, 2007-03, Vol.446 (7133), p.316-319

2007

Volltextzugriff (PDF)

PALB2 mutations in familial breast and pancreatic cancer

Familial cancer, 2011-06, Vol.10 (2), p.225-231

2011

Volltextzugriff (PDF)

PIK3CA Mutations in In situ and Invasive Breast Carcinomas

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (14), p.5674-5678

2010

Volltextzugriff (PDF)

Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients

PloS one, 2019-05, Vol.14 (5), p.e0216997-e0216997

2019

Volltextzugriff (PDF)

BRCA1 promoter methylation in sporadic breast tumors : relationship to gene expression profiles

Breast cancer research and treatment, 2005-05, Vol.91 (2), p.179-186

2005

Volltextzugriff (PDF)

Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4505-4509

2011

Volltextzugriff (PDF)

Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry

Cancer epidemiology, biomarkers & prevention, 2009-04, Vol.18 (4), p.1084-1091

2009

Volltextzugriff (PDF)

Altered Proliferation and Differentiation Properties of Primary Mammary Epithelial Cells from BRCA1 Mutation Carriers

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (4), p.1273-1278

2009

Volltextzugriff (PDF)

BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50

Cancer epidemiology, biomarkers & prevention, 2006-10, Vol.15 (10), p.1863-1870

2006

Volltextzugriff (PDF)

BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research

Breast cancer research and treatment, 2009-07, Vol.116 (2), p.379-386

2009

Volltextzugriff (PDF)

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers

Breast cancer research : BCR, 2010-11, Vol.12 (6), p.R95-R95, Article R95

2010

Volltextzugriff (PDF)

Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations

Cancer epidemiology, biomarkers & prevention, 2006-02, Vol.15 (2), p.359-363

2006

Volltextzugriff (PDF)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Nature communications, 2019-04, Vol.10 (1), p.1741-18, Article 1741

2019

Volltextzugriff (PDF)

NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth

Molecular cancer research, 2014-03, Vol.12 (3), p.408-420

2014

Volltextzugriff (PDF)

Isolation and initial characterization of the BRCA2 promoter

Oncogene, 1999-10, Vol.18 (44), p.6000-6012

1999

Volltextzugriff (PDF)

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

Breast cancer research and treatment, 2013-05, Vol.139 (1), p.193-198

2013

Volltextzugriff (PDF)

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry

Breast cancer research and treatment, 2015-06, Vol.151 (3), p.653-660

2015

Volltextzugriff (PDF)

Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers

Cancer research (Chicago, Ill.), 2004, Vol.64 (1), p.64-71

2004

Volltextzugriff (PDF)

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

The American journal of surgical pathology, 2007, Vol.31 (1), p.121-128

2007

Volltextzugriff (PDF)

Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk

Human molecular genetics, 2008-05, Vol.17 (9), p.1336-1348

2008

Volltextzugriff (PDF)

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Breast cancer research : BCR, 2006-01, Vol.8 (6), p.R66-R66, Article R66

2006

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaBreast Neoplasms - Genetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

X chromosomal abnormalities in basal-like human breast cancer

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups

A recurrent mutation in PALB2 in Finnish cancer families

PALB2 mutations in familial breast and pancreatic cancer

PIK3CA Mutations in In situ and Invasive Breast Carcinomas

Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients

BRCA1 promoter methylation in sporadic breast tumors : relationship to gene expression profiles

Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry

Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry

Altered Proliferation and Differentiation Properties of Primary Mammary Epithelial Cells from BRCA1 Mutation Carriers

BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50

BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers

Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth

Isolation and initial characterization of the BRCA2 promoter

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry

Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Aktive Filter

Suchergebnisse filtern